Form 4: AFLAC CFO Sells 13,000 Shares Under 10b5-1 Plan

AFLAC's Senior EVP and CFO, Max Broden, executed a pre-planned sale of 13,000 common shares at an average price of $117.665.

Summary

• Max Broden, Senior EVP and CFO of AFLAC INC, sold 13,000 shares of common stock.
• The transaction occurred on February 6, 2026.
• The shares were sold at a weighted average price of $117.665, with individual sales ranging from $117.37 to $118.115.
• Following the sale, Mr. Broden directly owns 122,062 shares and indirectly owns 340 shares through his spouse.
• The sale was conducted pursuant to a Rule 10b5-1(c) pre-arranged trading plan.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral event, leaning slightly positive due to the transparency of the 10b5-1 plan, which mitigates concerns typically associated with insider selling. It reflects routine executive financial planning rather than a negative signal about the company's fundamentals.

Positives

• The sale was executed under a Rule 10b5-1(c) plan, indicating it was pre-scheduled and not based on new, non-public information.
• Mr. Broden retains a significant direct beneficial ownership of 122,062 shares in AFLAC INC after the transaction.

Negatives

• A senior executive selling a notable number of shares, even under a 10b5-1 plan, can sometimes be perceived negatively by the market as it reduces their direct stake in the company.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider sales, particularly by C-suite executives, are closely watched by investors for signals about management's confidence in the company's future prospects. However, sales executed under a Rule 10b5-1 plan are generally viewed as less indicative of a change in sentiment, as they are pre-scheduled to avoid accusations of trading on material non-public information. This is a routine disclosure for such plans.

Comparison to Industry Standards

• Sales by executives under Rule 10b5-1 plans are a common practice across industries, including the insurance sector where AFLAC operates, allowing executives to diversify their holdings or manage liquidity without violating insider trading rules.
• Compared to other large insurance companies like MetLife (MET) or Prudential Financial (PRU), similar Form 4 filings detailing executive stock sales under 10b5-1 plans are regularly observed, indicating this is a standard practice for managing executive equity compensation.

Stakeholder Impact

• Shareholders: May view the sale as a routine diversification or liquidity event by a senior executive, especially given the 10b5-1 plan. Could be a minor negative signal if not fully understood as pre-planned.
• Employees: No direct impact.

Key Dates

Recommendation

The filing details a pre-planned insider sale under a 10b5-1 plan, which is a routine event for executive compensation and personal financial management. It does not provide new information about AFLAC's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Therefore, a "hold" recommendation is appropriate as this transaction is unlikely to significantly alter the investment thesis for AFLAC.

Keywords

AFLAC, AFL, Max Broden, CFO, Insider Sale, Form 4, 10b5-1 Plan, Common Stock, Executive Compensation, Share Ownership